Barely Significant
← all phrases

“a strong trend”

5,726 sentences · 5,726 papers · 7,352 search hits before verification · confirmed specimen

Sighted at

p=0.077

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

Young macrophages showed a strong trend of phagocytic activity at the beginning of the dark phase during the circadian rhythmicity testing, while the aged macrophages completely lost this diurnal cariation 91 .
Macrophage senescence in health and diseases.
Acta Pharm Sin B · 2024 · PMC10985037
How will these countries be able to respond to the further increasing demand in the near future? In spite of the overall impression of a strong trend toward gen- eral uniformity, we live in a dichotomized society in which certain socioeconomic disparities are not disappearing, and the differences between the rich and the poor, the haves and the have nots, are instead increasing.
Age and poverty as risk factors.
Environ Health Perspect · 1994 · PMC1567319
268 , 269 , 291 , 366 , 367 Of the 16 published studies that examined the effect of antimicrobial-impregnated CVCs on rates of CVC-related BSI, 12 found either a statistically significant reduction or a strong trend toward a reduction in rates of CVC-related BSI. 366 , 367 Aggregate analysis of the 15 studies that compared antimicrobial-impregnated CVCs with nonimpregnated CVCs, 366 , 367 encompassing a total of 4250 CVCs, shows that antimicrobial-impregnated CVCs are associated with a 40% reduction in CVC-rel
47 – 49 Interestingly, BRCA1 carriers appear to develop OC at an average of ~7 years earlier versus nonhereditary OC patients, while BRCA2 carriers do not display a strong trend for earlier diagnosis ( Table 1 ). 47 , 50 – 53 BRCA1 mutations account for over 80% of BRCA -associated OC diagnosed below the age of 50, while BRCA2 carriers account for ~60% of BRCA -associated OC diagnosed at >60 years old, despite the higher prevalence of BRCA1 versus BRCA2 mutations in OC.
Interestingly, while DNMT3A did not satisfy the criterion for concerted expression changes, it showed a strong trend for upregulation in the majority of the cell lines at 24 h (data not shown), suggesting that it may be considered as a potential target for combination therapy with doxorubicin and an additional agent targeting this specific DNA methyltransferase.